Cargando…
P11-18. Immunogenicity of Lactobacillus gasseri-FliC as an oral mucosal vaccine adjuvant for HIV
Autores principales: | Gunderson, S, Nordone, S, LaVoy, A, Zhang, L, Klaenhammer, T, Dean, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767652/ http://dx.doi.org/10.1186/1742-4690-6-S3-P163 |
Ejemplares similares
-
P10-02. Toll-like receptor activation profiles of wild-type, recombinant, and mutant Lactobacillus: implications for vaccine design
por: Stoeker, L, et al.
Publicado: (2009) -
Mucosal Immunogenicity of Genetically Modified Lactobacillus acidophilus Expressing an HIV-1 Epitope within the Surface Layer Protein
por: Kajikawa, Akinobu, et al.
Publicado: (2015) -
Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile
por: Bruxelle, Jean-François, et al.
Publicado: (2017) -
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC
por: Ghose, Chandrabali, et al.
Publicado: (2016) -
Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform
por: Bumgardner, Sara A., et al.
Publicado: (2018)